CPB Budapest 2017

• 24 patients with 32 recurrent keloids with two or more failed treatment modalities, 3 patients had been previously treated with EBRT • with perioperative HDR; 3 x 6 Gy to 5 mm total TREATMENT: RECURRENT KELOIDS dose of 18 Gy within 36 hours after the resection. • Disappearance of pain and pruritus was noticed in all patients (19). • FU 29.4 m, 2 keloid recurrences and 2 mildly hypertrophied scars. Local control: 94%. • Pigmentary abnormalities in 3 patients, • mild delay in the wound-healing process, 6 pat.

Jiang P, Baumann R, Dunst J et al. Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results.IJROBP 2016; 94:532-6.